Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Health Highlights: Dec. 7, 2021
Monoclonal antibody treatment for COVID-19 can be delivered by injection. The best available treatment for coronavirus infection just got a lot easier to...
What Time You Get Your COVID Shot Might Affect Immune Response
WEDNESDAY, Dec. 8, 2021 -- Can the time of day you get your COVID-19 vaccine affect how many antibodies you’ll make? A new study suggests that it c...
Gastro Symptoms of Menopause May Vary by Race
WEDNESDAY, Dec. 8, 2021 -- When a woman's periods begin to slow down and finally stop, digestive problems often pick up -- and new research suggests race and...
Half of Drinkers Who Think They're Fit to Drive Are Wrong: Study
WEDNESDAY, Dec. 8, 2021 -- If you think you're fine to drive after drinking, there's a good chance you're wrong, new research shows. The study found that...
NYC's Ban on Heating Oil Helped Clean the Air
WEDNESDAY, Dec. 8, 2021 -- New York City's ban on a certain type of heating oil led to significant reductions in air pollutants that pose a risk to health, new...
Convalescent Plasma Not Recommended in COVID-19
TUESDAY, Dec. 7, 2021 -- Convalescent plasma is not recommended for patients with nonsevere, severe, or critical COVID-19, according to a living World Health...
Psoriasis Ups Risk for Vascular Disease, Venous Thromboembolism
TUESDAY, Dec. 7, 2021 -- There is an increased risk for venous thromboembolism (VTE) and peripheral vascular disease (PVD) among patients with psoriatic...
Social Media Use Tied to Self-Reported Depression Symptoms
TUESDAY, Dec. 7, 2021 -- Social media use is associated with a greater likelihood of subsequent increase in depressive symptoms among adults initially free of...
U.S. to Pump $400 Million Into Vaccination Programs for Other Countries
TUESDAY, Dec. 7, 2021 -- The United States announced Monday that it will pour $400 million into a new program that should help other countries speed vaccines...
Biden Pledges to Lower Prescription Drug Prices for Americans
TUESDAY, Dec. 7, 2021 -- President Joe Biden promised cheaper prescription drugs for all Americans on Monday as his social agenda legislation winds its way...
FDA Approves Xaciato (clindamycin phosphate) Vaginal Gel as a Treatment for Bacterial Vaginosis
SAN DIEGO, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that the...
Spectrum Pharmaceuticals Submits New Drug Application for Poziotinib
Fast Track application is based on positive data in NSCLC HER2 exon 20 insertion mutations in previously treated patients Positive Results for Cohort 2 of...
Secura Bio Announces Copiktra (duvelisib) Strategic Focus On T-cell Lymphoma And Voluntary U.S. Withdrawal Of The Relapsed Or Refractory Follicular Lymphoma Indication
SUMMERLIN, Nev., Dec. 3, 2021 /PRNewswire/ -- Secura Bio, Inc. (Secura Bio) - (www.securabio.com), an integrated pharmaceutical company dedicated to the...
FDA Approves PreHevbrio (Hepatitis B Vaccine (Recombinant)) for the Prevention of Hepatitis B in Adults
PreHevbrio™ is the only approved 3-antigen hepatitis B vaccine for adults in the U.S. VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical...
BeyondSpring Pharmaceuticals Receives Complete Response Letter from the FDA for Plinabulin New Drug Application for Prevention of Chemotherapy-Induced Neutropenia (CIN)
NEW YORK, Dec. 01, 2021 (GLOBE NEWSWIRE) -- BeyondSpring Pharmaceuticals (the “Company” or “BeyondSpring”) (NASDAQ: BYSI), a global...
Secura Bio Announces U.S. Withdrawal of Farydak (panobinostat) NDA
SUMMERLIN, Nev., Nov. 30, 2021 /PRNewswire/ -- Secura Bio, Inc. (Secura Bio) - (www.securabio.com), an integrated pharmaceutical company dedicated to the...
Fennec Pharmaceuticals Expects to Receive Complete Response Letter from the FDA for its New Drug Application for Pedmark™ to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid Tumors
RESEARCH TRIANGLE PARK, N.C., November 29, 2021 – Fennec Pharmaceuticals Inc., a specialty pharmaceutical company, today announced that it expects to...
FDA Approves Cytalux (pafolacianine) Injection for Identification of Ovarian Cancer During Surgery
WEST LAFAYETTE, Ind., Nov. 29, 2021 /PRNewswire/ -- On Target Laboratories, Inc., a privately-held biotechnology company developing fluorescent imaging agents...
FDA Approves Livtencity (maribavir) for Post-Transplant Cytomegalovirus (CMV) Infection/Disease
- In the Phase 3 SOLSTICE study, more than twice the proportion of adult transplant recipients with refractory or resistant (R/R) CMV infection/disease...
FDA Approves Fyarro (sirolimus protein-bound particles) for the Treatment of Malignant Perivascular Epithelioid Cell Tumor (PEComa)
Fyarro is the first and only approved therapy for adults for the treatment of malignant PEComa, an ultra-rare and aggressive form of sarcoma with a strong...
MHRA Approves XEVUDY (sotrovimab), GlaxoSmithKline and Vir Biotechnology's Monoclonal Antibody Treatment for Patients with COVID‑19
MIAMI, Dec. 7, 2021. Brand Institute is proud to announce its successful partnership with GlaxoSmithKline and Vir Biotechnology in developing the brand name...
Acadia Pharmaceuticals Announces Positive Top-line Results from the Pivotal Phase 3 Lavender Trial of Trofinetide in Rett Syndrome
Trofinetide met co-primary efficacy endpoints demonstrating statistically significant improvement over placebo in the Rett Syndrome Behaviour Questionnaire...
Merck Announces Pause in Enrollment for Two Phase 3 Clinical Trials of Investigational, Once-Monthly, Oral Islatravir for Pre-Exposure Prophylaxis (PrEP) of HIV-1 infection
KENILWORTH, N.J.-- December 06, 2021 -- Merck, known as MSD outside the United States and Canada, today announced a pause in enrollment for the IMPOWER 22...
Johnson & Johnson COVID-19 Booster, Administered Six Months After Two-Dose Regimen of BNT162b2, Shows Substantial Increase in Antibody and T-cell Responses
NEW BRUNSWICK, N.J., Dec. 5, 2021. Johnson & Johnson (the Company) today announced preliminary results from an independent study, including a subset of...
Biohaven Reports Positive Topline Results from Pivotal Migraine Trial of Intranasal Zavegepant Demonstrating Ultra-Rapid Pain Relief by 15 Minutes
NEW HAVEN, Conn., Dec. 6, 2021 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced positive topline results from the...
Browse by News Type
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
- Drug Shortages
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.